Scientists hope the timely findings of the study could serve as a vital resource for clinicians seeking to optimise treatment plans for their patients
Gastrointestinal symptoms are the most common side effects reported Nausea typically improves with continued use and gradual dose increases Blood sugar control improved despite glucagon receptor activation Heart rate changes require monitoring in certain patient groups Long-term safety data is still being collected in Phase 3 trials UK Availability Timeline and What to Expect For those eagerly awaiting the opportunity to try Retatrutide, understanding the regulatory pathway and realistic timeline expectations is important
GeroScience 41 (5), 655670
By purchasing from our website, you acknowledge and agree to the following conditions: Research Use Only - All peptides, compounds, and related products are supplied exclusively for scientific research, analytical testing, and laboratory use by suitably qualified individuals or licensed organisations
Frequent urination is one possible side effect because it can cause diabetes insipidus, says Hudspeth
